Some physicians are still skittish about prescribing generic drugs, but the manufacturers of these less expensive medicines say they are increasingly important and there is less need to worry about their quality and safety than ever before. Kathleen Jaeger, president and CEO of the Generic Pharmaceutical Association, tells the Chicago Tribune's Bruce Japsen about the generic industry's assurances of quality, as well as regulations that have helped this cause.
Improving the Safety of Generic Pharmaceuticals
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Some physicians are still skittish about prescribing generic drugs, but the manufacturers of these less expensive medicines say they are increasingly important and there is less need to worry about their quality and safety than ever before. Kathleen Jaeger, president and CEO of the Generic Pharmaceutical Association, tells the Chicago Tribune's Bruce Japsen about the generic industry's assurances of quality, as well as regulations that have helped this cause.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Phase 3 study results of plozasiran in patients with FCS
FCS and SHTG: Are We Meeting the Need?
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Level Up Your Skills: Tailoring Management of HF
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?